Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Bioatla Inc (BCAB)

Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress GlobeNewswire - Thu Nov 7, 3:01PM CST

BCAB : 2.10 (-5.41%)
BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024 GlobeNewswire - Thu Oct 31, 7:00AM CDT

BCAB : 2.10 (-5.41%)
BioAtla Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting GlobeNewswire - Fri Oct 4, 8:05AM CDT

BCAB : 2.10 (-5.41%)
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors PR Newswire - Thu Dec 29, 2022

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that Scott A. Smith and Elisha W. Finney have been appointed as...

BCAB : 2.10 (-5.41%)
VTRS : 12.96 (-1.67%)
Himalaya Therapeutics Announces Highlights of Recent Clinical Progress PR Newswire - Tue Nov 8, 2022

/PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization of a novel class of...

BCAB : 2.10 (-5.41%)
Himalaya Therapeutics Announces Interim Phase 2 Results for Mecbotamab vedotin (HTBA3011) PR Newswire - Mon Sep 12, 2022

/PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization of a novel class of...

BCAB : 2.10 (-5.41%)
BioAtla Reports Second Quarter 2022 Financial Results And Highlights Recent Progress Globe Newswire - Tue Aug 9, 2022

Mecbotamab vedotin (BA3011) Phase 2 preliminary observations in Non-Small Cell Lung Carcinoma (NSCLC) supports advancing to the registrational stage of the...

BCAB : 2.10 (-5.41%)
BioAtla to Announce Second Quarter 2022 Financial Results and Provide Business Highlights on August 9, 2022 Globe Newswire - Tue Aug 2, 2022

SAN DIEGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of...

BCAB : 2.10 (-5.41%)
BioAtla Reports First Quarter 2022 Financial Results and Highlights Recent Progress Globe Newswire - Wed May 4, 2022

– Mecbotamab vedotin (BA3011) sarcoma Phase 2 top-line interim data support advancing with UPS and osteosarcoma – – Mecbotamab vedotin (BA3011) Phase 2...

BCAB : 2.10 (-5.41%)
BioAtla to Announce First Quarter 2022 Financial Results and Provide Business Highlights on May 4, 2022 Globe Newswire - Fri Apr 8, 2022

SAN DIEGO, April 08, 2022 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of...

BCAB : 2.10 (-5.41%)

Barchart Exclusives

3 Best Dividend-growth Stocks Soon To Be Crowned Kings Barchart - 1 hour ago
These three quality companies represent an excellent opportunity for long-term income generation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot